My Treatment Approach to Giant Cell Arteritis

Thomas D. Garvey; Matthew J. Koster; Kenneth J. Warrington

doi:10.1016/j.mayocp.2021.02.013

My Treatment Approach to Giant Cell Arteritis

Thomas D. Garvey, Matthew J. Koster, Kenneth J. Warrington

Rheumatology

Research output: Contribution to journal › Review article › peer-review

Abstract

Giant cell arteritis (GCA) is the most common primary systemic vasculitis in adults 50 years or older. Expanded use of advanced arterial imaging has assisted both in the diagnosis of GCA and recognition of disease subsets. Although glucocorticoids have been the mainstay of treatment for almost 7 decades, new therapeutic options have emerged. This review aims to provide the clinician with a pragmatic approach to evaluating and managing patients with GCA while also addressing recent diagnostic and therapeutic developments.

Original language	English (US)
Pages (from-to)	1530-1545
Number of pages	16
Journal	Mayo Clinic proceedings
Volume	96
Issue number	6
DOIs	https://doi.org/10.1016/j.mayocp.2021.02.013
State	Published - Jun 2021

ASJC Scopus subject areas

General Medicine

Access to Document

10.1016/j.mayocp.2021.02.013

Cite this

@article{e7893bc253c141808d74cd42242e00e7,

title = "My Treatment Approach to Giant Cell Arteritis",

abstract = "Giant cell arteritis (GCA) is the most common primary systemic vasculitis in adults 50 years or older. Expanded use of advanced arterial imaging has assisted both in the diagnosis of GCA and recognition of disease subsets. Although glucocorticoids have been the mainstay of treatment for almost 7 decades, new therapeutic options have emerged. This review aims to provide the clinician with a pragmatic approach to evaluating and managing patients with GCA while also addressing recent diagnostic and therapeutic developments.",

author = "Garvey, {Thomas D.} and Koster, {Matthew J.} and Warrington, {Kenneth J.}",

note = "Publisher Copyright: {\textcopyright} 2021 Mayo Foundation for Medical Education and Research",

year = "2021",

month = jun,

doi = "10.1016/j.mayocp.2021.02.013",

language = "English (US)",

volume = "96",

pages = "1530--1545",

journal = "Mayo Clinic proceedings",

issn = "0025-6196",

publisher = "Elsevier Science",

number = "6",

}

TY - JOUR

T1 - My Treatment Approach to Giant Cell Arteritis

AU - Garvey, Thomas D.

AU - Koster, Matthew J.

AU - Warrington, Kenneth J.

PY - 2021/6

Y1 - 2021/6

N2 - Giant cell arteritis (GCA) is the most common primary systemic vasculitis in adults 50 years or older. Expanded use of advanced arterial imaging has assisted both in the diagnosis of GCA and recognition of disease subsets. Although glucocorticoids have been the mainstay of treatment for almost 7 decades, new therapeutic options have emerged. This review aims to provide the clinician with a pragmatic approach to evaluating and managing patients with GCA while also addressing recent diagnostic and therapeutic developments.

AB - Giant cell arteritis (GCA) is the most common primary systemic vasculitis in adults 50 years or older. Expanded use of advanced arterial imaging has assisted both in the diagnosis of GCA and recognition of disease subsets. Although glucocorticoids have been the mainstay of treatment for almost 7 decades, new therapeutic options have emerged. This review aims to provide the clinician with a pragmatic approach to evaluating and managing patients with GCA while also addressing recent diagnostic and therapeutic developments.

UR - http://www.scopus.com/inward/record.url?scp=85107336306&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85107336306&partnerID=8YFLogxK

U2 - 10.1016/j.mayocp.2021.02.013

DO - 10.1016/j.mayocp.2021.02.013

M3 - Review article

C2 - 34088416

AN - SCOPUS:85107336306

SN - 0025-6196

VL - 96

SP - 1530

EP - 1545

JO - Mayo Clinic proceedings

JF - Mayo Clinic proceedings

IS - 6

ER -

My Treatment Approach to Giant Cell Arteritis

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this